Supernus Pharmaceuticals
SUPN
#4329
Rank
โ‚ฌ1.91 B
Marketcap
34,68ย โ‚ฌ
Share price
0.88%
Change (1 day)
38.63%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): โ‚ฌ65.89 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.65 Billion. In 2023 the company made an earning of โ‚ฌ4.92 Million a decrease over its 2022 earnings that were of โ‚ฌ64.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ65.89 M1237.27%
2023 โ‚ฌ4.92 M-92.36%
2022 โ‚ฌ64.45 M-29.8%
2021 โ‚ฌ91.81 M-49.79%
2020 โ‚ฌ0.18 B12.99%
2019 โ‚ฌ0.16 B7.58%
2018 โ‚ฌ0.15 B54.9%
2017 โ‚ฌ97.12 M84.25%
2016 โ‚ฌ52.71 M202.27%
2015 โ‚ฌ17.43 M-462.04%
2014 -โ‚ฌ4.82 Million-94%
2013 -โ‚ฌ80.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.21 Billion-392.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.41 B 1,953.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.64 B 13,904.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.54 Billion-9,592.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.44 B 9,251.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.48 B 25,280.12%๐Ÿ‡บ๐Ÿ‡ธ USA